An Overview of PARPi & Adverse Event Management Podcast

Co-Host: Stephen Freedland, MD

At the conclusion of this activity, participants will be able to:
1. Identify approved PARP Inhibitors for prostate cancer and patients who may benefit from PARP Inhibitor‐based therapy.
2. Evaluate available clinical safety and efficacy data for PARP Inhibitors.
3. Describe indications and contraindications for PARP Inhibitors in patients with advanced prostate cancer.
4. Identify how to manage adverse events that patients may experience while taking a PARP Inhibitors.

ACKNOWLEDGEMENT: 

This podcast was funded by and developed in collaboration with AstraZeneca.

Patient Education Resources

To encourage and support the participant's care of their patients, this activity provides access to Urology Care Foundation existing resources for caregivers and their patients on Genomic Testing for Prostate Cancer.

Genomic-Testing-for-Prostate-Cancer-Fact-Sheet

The “Prostate Cancer Caregiver Podcast Series” is designed to help others connect with a diverse group of people who have felt the impact of prostate cancer in their lives and empower them on their journey. This series is geared toward helping give support, hope and guidance to prostate cancer caregivers. These podcasts allow people to listen to six unique stories - each focusing on prostate cancer topics from the views of caregivers. Listeners may reflect on how these stories may relate to their own lives.

https://www.urologyhealth.org/healthy-living/care-blog/2021/prostate-cancer-caregiver-podcast-series

The Urology Care Foundation is the official Foundation of the American Urological Association. For more patient resources from the Urology Care Foundation on Prostate Cancer and Prostate Health, please visit UrologyHealth.org.